Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Agulnik JS"'
Autor:
Kasymjanova G; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Rizzolo A; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Pepe C; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Friedmann JE; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Small D; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Spicer J; Division of Thoracic Thoracic Oncology, McGill University Health Centre, MUHC, Montreal, QC H4A 3S5, Canada., Lecavalier-Barsoum M; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Sultanem K; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Wang H; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Spatz A; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Cohen V; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Agulnik JS; Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Nov 14; Vol. 29 (11), pp. 8677-8685. Date of Electronic Publication: 2022 Nov 14.
Autor:
Ezeife DA; Department of Oncology, Tom Baker Cancer Center, 1331 29 St NW, Toronto, ON T2N 4N2, Canada University of Calgary, Calgary, AB, Canada., Spackman E; University of Calgary, Calgary, AB, Canada., Juergens RA; Juravinski Cancer Center, McMaster University, Hamilton, ON, Canada., Laskin JJ; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Agulnik JS; Jewish General Hospital, McGill University, Montreal, QC, Canada., Hao D; Tom Baker Cancer Center, Calgary, AB, Canada University of Calgary, Calgary AB, Canada., Laurie SA; Ottawa Hospital Research Institute/Department of Medicine, University of Ottawa, Ottawa, ON, Canada., Law JH; Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Le LW; Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Kiedrowski LA; Guardant Health, Inc., Redwood City, CA, Canada., Melosky B; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Shepherd FA; Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Cohen V; Jewish General Hospital, McGill University, Montreal, QC, Canada., Wheatley-Price P; Ottawa Hospital Research Institute/Department of Medicine, University of Ottawa, Ottawa, ON, Canada., Vandermeer R; Niagara Health, St. Catharines, ON, Canada., Li JJ; Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Fernandes R; Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Shokoohi A; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Lanman RB; Guardant Health, Inc., Redwood City, CA, Canada., Leighl NB; Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Jul 26; Vol. 14, pp. 17588359221112696. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).
Autor:
Agulnik JS; Peter Brojde Lung Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada., Papadakis AI; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Pepe C; Peter Brojde Lung Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada., Sakr L; Peter Brojde Lung Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada., Small D; Peter Brojde Lung Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada., Wang H; Department of Pathology, Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Kasymjanova G; Peter Brojde Lung Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada., Spatz A; OPTILAB-Montreal MUHC & Department of Laboratory Medicine, McGill University Health Center, Montreal, QC H3T 1E2, Canada., Cohen V; Peter Brojde Lung Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Feb 14; Vol. 29 (2), pp. 1107-1116. Date of Electronic Publication: 2022 Feb 14.
Autor:
Agulnik JS; Peter Brojde Lung Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada., Kasymjanova G; Peter Brojde Lung Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada., Pepe C; Peter Brojde Lung Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada., Hurry M; AstraZeneca Canada, Mississauga, ON L4Y 1M4, Canada., Walton RN; AstraZeneca Canada, Mississauga, ON L4Y 1M4, Canada., Sakr L; Peter Brojde Lung Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada., Cohen V; Peter Brojde Lung Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada., Small D; Peter Brojde Lung Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Dec 07; Vol. 28 (6), pp. 5179-5191. Date of Electronic Publication: 2021 Dec 07.
Autor:
Kasymjanova G; Peter Brojde Lung Cancer Center, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Anwar A; Department of Oncology, McGill University, Montreal, QC H3T1E2, Canada., Cohen V; Segal Cancer Centre, Medical Oncology, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Sultanem K; Segal Cancer Centre, Radiation Oncology, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Pepe C; Peter Brojde Lung Cancer Center, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Sakr L; Peter Brojde Lung Cancer Center, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Friedmann J; Segal Cancer Centre, Medical Oncology, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Agulnik JS; Peter Brojde Lung Cancer Center, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Oct 20; Vol. 28 (6), pp. 4247-4255. Date of Electronic Publication: 2021 Oct 20.
Autor:
Kasymjanova G; Peter Brojde Lung Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Montreal, QC., Jagoe RT; Peter Brojde Lung Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Montreal, QC., Pepe C; Peter Brojde Lung Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Montreal, QC., Sakr L; Peter Brojde Lung Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Montreal, QC., Cohen V; Peter Brojde Lung Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Montreal, QC., Small D; Peter Brojde Lung Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Montreal, QC., Muanza TM; Radiation Oncology, Segal Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Montreal, QC., Agulnik JS; Peter Brojde Lung Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Montreal, QC.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2018 Dec; Vol. 25 (6), pp. e610-e614. Date of Electronic Publication: 2018 Dec 01.
Autor:
Kasymjanova G; Peter Brojde Lung Cancer Center, Segal Cancer Center, Jewish General Hospital, Montreal H3T 1E2, Canada. Electronic address: gkasymja@jgh.mcgill.ca., Tran AT; Peter Brojde Lung Cancer Center, Segal Cancer Center, Jewish General Hospital, Montreal H3T 1E2, Canada., Cohen V; Peter Brojde Lung Cancer Center, Segal Cancer Center, Jewish General Hospital, Montreal H3T 1E2, Canada., Pepe C; Peter Brojde Lung Cancer Center, Segal Cancer Center, Jewish General Hospital, Montreal H3T 1E2, Canada., Sakr L; Peter Brojde Lung Cancer Center, Segal Cancer Center, Jewish General Hospital, Montreal H3T 1E2, Canada., Small D; Peter Brojde Lung Cancer Center, Segal Cancer Center, Jewish General Hospital, Montreal H3T 1E2, Canada., Agulnik JS; Peter Brojde Lung Cancer Center, Segal Cancer Center, Jewish General Hospital, Montreal H3T 1E2, Canada., Jagoe RT; Peter Brojde Lung Cancer Center, Segal Cancer Center, Jewish General Hospital, Montreal H3T 1E2, Canada.
Publikováno v:
Journal of integrative medicine [J Integr Med] 2018 Nov; Vol. 16 (6), pp. 390-395. Date of Electronic Publication: 2018 Sep 21.
Autor:
Esfahani K; Department of Oncology, Segal Cancer Center, Sir Mortimer B. Davis Jewish General Hospital , Montreal, QC , Canada., Agulnik JS; Division of Pulmonary Diseases, Department of Oncology, Peter Brojde Cancer Center , Montreal, QC , Canada., Cohen V; Department of Oncology, Segal Cancer Center, Sir Mortimer B. Davis Jewish General Hospital , Montreal, QC , Canada.
Publikováno v:
Frontiers in oncology [Front Oncol] 2014 Jul 21; Vol. 4, pp. 174. Date of Electronic Publication: 2014 Jul 21 (Print Publication: 2014).
Autor:
Gagnon B; Department of Family Medicine and Emergency Medicine, Université Laval, Centre de Recherché du Le Centre Hospitalier Universitaire de Québec, 9 rue McMahon, Local 1899-6, Quebec, Quebec City, Quebec QC G1R 2J6, Canada., Agulnik JS, Gioulbasanis I, Kasymjanova G, Morris D, MacDonald N
Publikováno v:
British journal of cancer [Br J Cancer] 2013 Oct 15; Vol. 109 (8), pp. 2066-71. Date of Electronic Publication: 2013 Sep 24.
Autor:
Smith BM; Jewish General Hospital affiliated with McGill University, Montreal, Canada. benjamin.m.smith@mcgill.ca, Schwartzman K, Kovacina B, Taylor J, Kasymjanova G, Brandao G, Agulnik JS
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2012 Apr; Vol. 76 (1), pp. 61-6. Date of Electronic Publication: 2011 Sep 25.